fig6

Characterization of acquired nutlin-3 resistant non-small cell lung cancer cells

Figure 6. Cisplatin-induced cell death is reduced in A549.R2 cells. Percentage survival (A) and percentage cell death (B) of A549 and A549.R2 cells treated with cisplatin (0-50 µmol/L) for 96 hours determined by the IncuCyte ZOOM cytotoxicity assay. Data presented as mean +/- SD of at least 3 biological replicates

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/